Drugs / EmdogainⓇ
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02218515 | Sep 2010 → Sep 2012 | chronic periodontitis | Haner Direskeneli, Prof | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EmdogainⓇ | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02218515 ↗ |
| Known as | Enamel Matrix Derivative | “EmdogainⓇ(Enamel Matrix Derivative)” NCT02218515 ↗ |
| Modality | Protein / enzyme biologic | “Biological: EmdogainⓇ(Enamel Matrix Derivative)” NCT02218515 ↗ |